Lactoferrin Infant Feeding Trial - LIFT_Canada
Sponsor: Canadian Institutes of Health Research (CIHR)
Listed as NCT03367013, this PHASE3 trial focuses on Morbidity;Newborn and Preterm Infant and remains completed. Sponsored by Canadian Institutes of Health Research (CIHR), it has been updated 15 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Dec 2024 — Present [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Sep 2024 — Dec 2024 [monthly]
Active Not Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
-
Sep 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
-
Sep 2022 — Sep 2023 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
▶ Show 10 earlier versions
-
Oct 2021 — Sep 2022 [monthly]
Recruiting PHASE3
-
Apr 2021 — Oct 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Jul 2020 — Nov 2020 [monthly]
Recruiting PHASE3
Status: Active Not Recruiting → Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Sep 2019 — Jun 2020 [monthly]
Recruiting PHASE3
-
Mar 2019 — Sep 2019 [monthly]
Recruiting PHASE3
-
Jul 2018 — Mar 2019 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Dec 2017 — Jul 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Institutes of Health Research (CIHR)
- Dr. Elizabeth Asztalos
- National Health and Medical Research Council, Australia
- Sunnybrook Research Institute (Toronto, Ontario)
For direct contact, visit the study record on ClinicalTrials.gov .